Quadrant Capital Group’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.18M Buy
16,019
+95
+0.6% +$6.97K 0.04% 405
2025
Q1
$1.82M Buy
15,924
+12,955
+436% +$1.48M 0.07% 215
2024
Q4
$150K Buy
2,969
+257
+9% +$13K 0.01% 833
2024
Q3
$126K Buy
2,712
+670
+33% +$31K 0.01% 938
2024
Q2
$66.3K Buy
2,042
+1
+0% +$32 ﹤0.01% 1254
2024
Q1
$51.4K Sell
2,041
-66
-3% -$1.66K ﹤0.01% 1387
2023
Q4
$68.4K Buy
2,107
+448
+27% +$14.6K 0.01% 1212
2023
Q3
$45.2K Buy
1,659
+347
+26% +$9.45K ﹤0.01% 1318
2023
Q2
$29.2K Buy
1,312
+103
+9% +$2.29K ﹤0.01% 1521
2023
Q1
$26.2K Sell
1,209
-229
-16% -$4.96K ﹤0.01% 1560
2022
Q4
$29.2K Sell
1,438
-133
-8% -$2.7K ﹤0.01% 1469
2022
Q3
$40K Buy
1,571
+1,378
+714% +$35.1K 0.01% 1159
2022
Q2
$5K Sell
193
-74
-28% -$1.92K ﹤0.01% 1947
2022
Q1
$6K Buy
267
+74
+38% +$1.66K ﹤0.01% 1838
2021
Q4
$4K Sell
193
-122
-39% -$2.53K ﹤0.01% 1939
2021
Q3
$6K Buy
315
+117
+59% +$2.23K ﹤0.01% 1792
2021
Q2
$4K Sell
198
-23
-10% -$465 ﹤0.01% 1902
2021
Q1
$5K Buy
221
+28
+15% +$633 ﹤0.01% 1769
2020
Q4
$5K Hold
193
﹤0.01% 1678
2020
Q3
$3K Hold
193
﹤0.01% 1691
2020
Q2
$3K Sell
193
-1,946
-91% -$30.2K ﹤0.01% 1786
2020
Q1
$26K Buy
2,139
+59
+3% +$717 ﹤0.01% 1174
2019
Q4
$25K Hold
2,080
﹤0.01% 1635
2019
Q3
$29K Hold
2,080
﹤0.01% 1452
2019
Q2
$23K Buy
2,080
+1,988
+2,161% +$22K ﹤0.01% 1583
2019
Q1
$1K Sell
92
-55
-37% -$598 ﹤0.01% 2141
2018
Q4
$1K Buy
147
+55
+60% +$374 ﹤0.01% 2028
2018
Q3
$1K Hold
92
﹤0.01% 1989
2018
Q2
$1K Sell
92
-145
-61% -$1.58K ﹤0.01% 1996
2018
Q1
$3K Buy
237
+45
+23% +$570 ﹤0.01% 1686
2017
Q4
$3K Hold
192
﹤0.01% 1638
2017
Q3
$3K Hold
192
﹤0.01% 1630
2017
Q2
$2K Hold
192
﹤0.01% 1568
2017
Q1
$2K Buy
+192
New +$2K ﹤0.01% 1580